Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial

Authors and Affiliations

1. National Cancer Center Hospital East, Kashiwa, Japan

   Toru Mukohara

2. Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

   Yeon Hee Park

3. NEXT Oncology, San Antonio, TX, USA

   David Sommerhalder

4. National Cancer Center Hospital, Tokyo, Japan

   Kan Yonemori

5. Sarah Cannon Research Institute, Nashville, TN, USA

   Erika Hamilton

6. Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

   Sung-Bae Kim

7. Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea

   Jee Hyun Kim

8. Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan

   Hiroji Iwata

9. Kanagawa Cancer Center, Yokohama, Japan

   Toshinari Yamashita

10. The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Rachel M. Layman

11. Hoag Family Cancer Institute, Newport Beach, CA, USA

    Monica Mita

12. Saint John of God Subiaco Hospital, Perth, Western Australia, Australia

    Timothy Clay

13. Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea

    Yee Soo Chae

14. Western Health, Sunshine Hospital, St Albans, Victoria, Australia

    Catherine Oakman

15. Swedish Cancer Institute, First Hill-True Family Women’s Cancer Center, Seattle, WA, USA

    Fengting Yan

16. Yonsei University College of Medicine, Seoul, Republic of Korea

    Gun Min Kim

17. Seoul National University Hospital, Seoul National University College of Medicine, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea

    Seock-Ah Im

18. Peter MacCallum Cancer Centre and Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia

    Geoffrey J. Lindeman

19. University of California, San Francisco, CA, USA

    Hope S. Rugo

20. Pfizer, San Diego, CA, USA

    Marlon Liyanage, Michelle Saul, Christophe Le Corre & Li Liu

21. Pfizer, Collegeville, PA, USA

    Athanasia Skoura

22. Pfizer, San Francisco, CA, USA

    Meng Li

23. Yale School of Medicine, New Haven, CT, USA

    Patricia M. LoRusso

Corresponding authors

Correspondence to Meng Li or Patricia M. LoRusso.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions